Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
NEXI-003
i
Other names:
NEXI-003
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
NexImmune
Drug class:
Survivin inhibitor, HPV-16 E6 protein inhibitor, HPV-16 E7 protein inhibitor, CD8 T-cell agonist, HPV-18 E6 protein inhibitor, HPV-18 E7 protein inhibitor
Related drugs:
‹
MVP-S (3)
SVN53-67/M57-KLH peptide vaccine (1)
PC-002 (1)
ABBV-184 (0)
terameprocol (0)
MANA-312 (0)
MultiTAA T cell therapy (0)
PDC*lung (0)
SL-701 (0)
LY2181308 (0)
Versamune HPV (1)
HB-200 (1)
BNT113 (0)
CRTE7A2-01 (0)
HB-201 (0)
HPV-T (0)
ISA101 (0)
MEDI0457 (0)
RTX-321 (0)
VGX-3100 (0)
TG4001 (0)
DPX-E7 (0)
E7 TCR-T (0)
KITE-439 (0)
axalimogene filolisbac (0)
TSC-200-A0201 (0)
ADP-A2M4CD8 (1)
AB248 (0)
AB821 (0)
EU204 (0)
Human tyrosinase DNA Vaccine (0)
IL-15 DC (0)
IMA203CD8 (0)
LB4330 (0)
NEXI-001 (0)
NEXI-002 (0)
SLC-3010 (0)
rhIL-15 (0)
MVP-S (3)
SVN53-67/M57-KLH peptide vaccine (1)
PC-002 (1)
ABBV-184 (0)
terameprocol (0)
MANA-312 (0)
MultiTAA T cell therapy (0)
PDC*lung (0)
SL-701 (0)
LY2181308 (0)
Versamune HPV (1)
HB-200 (1)
BNT113 (0)
CRTE7A2-01 (0)
HB-201 (0)
HPV-T (0)
ISA101 (0)
MEDI0457 (0)
RTX-321 (0)
VGX-3100 (0)
TG4001 (0)
DPX-E7 (0)
E7 TCR-T (0)
KITE-439 (0)
axalimogene filolisbac (0)
TSC-200-A0201 (0)
ADP-A2M4CD8 (1)
AB248 (0)
AB821 (0)
EU204 (0)
Human tyrosinase DNA Vaccine (0)
IL-15 DC (0)
IMA203CD8 (0)
LB4330 (0)
NEXI-001 (0)
NEXI-002 (0)
SLC-3010 (0)
rhIL-15 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login